Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Palo Alto Networks

    Protecting Pharma from cyber attacks and systems misuse helping to ensure IP Protection and availability in manufacturing environments

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    Genetic Digital

    We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

    View Profile

    Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

    - PMLiVE

    Nmblr

    From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

    View Profile

    IT solutions

    Company Details

    Palo Alto Networks
    4401 Great America Parkway, Santa Clara, CA, 95054, USA
    Contact Palo Alto Networks
    Website

     Latest Content from PMHub 

    Beat inflation with virtual meetings and programs

    White Papers and Resources | August 29, 2022 | Impetus Digital

    At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down...

    Engaging KOLs & Gaining Insights in Pharma’s New Normal

    Videos and Podcasts | August 25, 2022 | Impetus Digital

    Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

    ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS

    Press Releases | August 24, 2022 | Wilmington Healthcare

    With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...

    Medscape: At the Heart of Education at #ESCCongress

    Press Releases | August 23, 2022 | Medscape Education

    Medscape Education Global will attend ESC from September 26-29 to host live symposia and an in-person event on key topics in cardiology.

    Learning Program Webinar Series & Community Board

    White Papers and Resources | August 22, 2022 | Impetus Digital

    A Customer Story

    The Sofa Sessions – The Third Page

    Videos and Podcasts | August 22, 2022 | Page & Page Health

    Webcast: From perceptions to prescribing: Combining forces with next-generation tracking and benchmarking to accelerate brand performance

    White Papers and Resources | August 22, 2022 | Inizio

    In this webcast we demonstrate RP and STEM's integrated approaches which gives clients the level of insights they need to accelerate brand performance.

    Medscape Education Invites Clinicians to Connect to the Conversation With New Mental Health and Wellness Learning Center

    Press Releases | August 19, 2022 | Medscape Education

    Medscape Education, the leading destination for continuous professional development for healthcare professionals, has launched Building Bridges Between Mental Health and Wellness, a learning center focusing on mental health and wellness for both patients...

    There’s No Going Back: How COVID-19 will Change Pharma Forever

    Videos and Podcasts | August 19, 2022 | Impetus Digital

    Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

    Shaping the dermatology landscape: Independent expert analysis of the pipeline in 5 disease areas

    White Papers and Resources | August 18, 2022 | Avalere Health

    Leading dermatologists discuss the innovations shaping 5 chronic skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa—and share the challenges and opportunities for biopharmaceutical companies developing innovative treatments.